TAOP vs CVKD Comparison

Taoping Inc is a provider of cloud-based technology solutions, smart city IoT platforms, digital advertising delivery systems, and internet-based information distribution systems in China. The company has three reportable segments. The Cloud-based Technology segment includes cloud-based products, high-end data storage servers, advertising services, and customized software solutions for private sector customers. The Traditional Information Technology segment includes project-based technology products and services sold to the public sector, including Geographic Information Systems, Digital Public Security Technology, and Digital Hospital Information Systems. The Smart Elevator segment provides elevator sales, installation, maintenance, renovation, and cloud-based maintenance services.

Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to treat heparin-induced thrombocytopenia (HIT), a deadly immune-mediated thrombotic disorder. The pipeline includes two additional clinical-stage assets: tecarfarin and frunexian. Tecarfarin is an oral vitamin K antagonist (VKA) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation. Frunexian is a first-in-class, Phase 2-ready intravenous Factor XIa inhibitor designed for acute care settings where contact activation of coagulation by medical devices or artificial surfaces.